Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Hisse Senetlerindeki Sıralama #25697
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Hisse Fiyatı
$2.09
Son senkronizasyon: 2022-03-21
Piyasa Değeri
$47.04M
Değişim (1 gün)
-0.48%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Recro Pharma, Inc. (REPH)

Kategori

Recro Pharma, Inc. (REPH) için kazanç
2026 itibarıyla kazanç TTM: 0
Recro Pharma, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Recro Pharma, Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç